Literature DB >> 8181568

An extensive network of PHF tau-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease.

M L Schmidt1, A G DiDario, V M Lee, J Q Trojanowski.   

Abstract

Previous studies demonstrated paired helical filament tau (PHF tau) in neuritic but not diffuse beta-amyloid (A beta) plaques in Alzheimer's disease (AD). Re-examination of amyloid deposits with antibodies to A beta and PHF tau by conventional and confocal microscopy using double label immunohistochemistry showed that PHF tau is a component of both diffuse and neuritic plaques in AD. Unlike controls, a dense network of PHF tau positive dystrophic neurites extended throughout the AD neocortex permeating nearly all neuritic and diffuse plaques. Thus, PHF tau-rich dystrophic neurites are common components of neuritic and diffuse plaques in AD neocortex.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8181568     DOI: 10.1016/0014-5793(94)00259-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  Brain trauma induces massive hippocampal neuron death linked to a surge in beta-amyloid levels in mice overexpressing mutant amyloid precursor protein.

Authors:  D H Smith; M Nakamura; T K McIntosh; J Wang; A Rodríguez; X H Chen; R Raghupathi; K E Saatman; J Clemens; M L Schmidt; V M Lee; J Q Trojanowski
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

2.  Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia.

Authors:  J L Holton; J Ghiso; T Lashley; A Rostagno; C J Guerin; G Gibb; H Houlden; H Ayling; L Martinian; B H Anderton; N W Wood; R Vidal; G Plant; B Frangione; T Revesz
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 3.  Autophagy failure in Alzheimer's disease--locating the primary defect.

Authors:  Ralph A Nixon; Dun-Sheng Yang
Journal:  Neurobiol Dis       Date:  2011-02-03       Impact factor: 5.996

4.  Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.

Authors:  Niklas Mattsson; Philip S Insel; Michael Donohue; Susan Landau; William J Jagust; Leslie M Shaw; John Q Trojanowski; Henrik Zetterberg; Kaj Blennow; Michael W Weiner
Journal:  Brain       Date:  2014-12-24       Impact factor: 13.501

5.  Enhanced β-secretase processing alters APP axonal transport and leads to axonal defects.

Authors:  Elizabeth M Rodrigues; April M Weissmiller; Lawrence S B Goldstein
Journal:  Hum Mol Genet       Date:  2012-07-27       Impact factor: 6.150

6.  The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease.

Authors:  Yasuo Ihara; Maho Morishima-Kawashima; Ralph Nixon
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

7.  Loss of P2Y₂ nucleotide receptors enhances early pathology in the TgCRND8 mouse model of Alzheimer's disease.

Authors:  Deepa Ajit; Lucas T Woods; Jean M Camden; Christina N Thebeau; Farid G El-Sayed; Glen W Greeson; Laurie Erb; Michael J Petris; Douglas C Miller; Grace Y Sun; Gary A Weisman
Journal:  Mol Neurobiol       Date:  2013-11-06       Impact factor: 5.590

8.  A comparison of Aβ amyloid pathology staging systems and correlation with clinical diagnosis.

Authors:  Susana Boluda; Jon B Toledo; David J Irwin; Kevin M Raible; Matt D Byrne; Edward B Lee; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2014-06-12       Impact factor: 17.088

Review 9.  Deciphering the mechanism underlying late-onset Alzheimer disease.

Authors:  Dimitrije Krstic; Irene Knuesel
Journal:  Nat Rev Neurol       Date:  2012-11-27       Impact factor: 42.937

10.  Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy.

Authors:  M L Schmidt; K A Robinson; V M Lee; J Q Trojanowski
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.